Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone for Threatened Preterm Labor (PROTO)
NCT01286246Phase 4Terminated
- Sponsor
- University of Calgary
- Start
- Jan 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of progesterone in preterm birth, sponsored by University of Calgary. Started Jan 2011; status: terminated.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT01286246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01286246.